About NeuroStar
NeuroStar is a company based in Malvern (United States) founded in 2003. NeuroStar has raised $118.69 million across 7 funding rounds from investors including Pfizer, General Electric and New Leaf Venture Partners. The company has 716 employees as of December 31, 2024. NeuroStar offers products and services including NeuroStar TMS System and NeuroStar Advanced Therapy. NeuroStar operates in a competitive market with competitors including Flow Neuroscience, Magstim, Soterix Medical, Neuroprex and NeuroQore, among others.
- Headquarter Malvern, United States
- Employees 716 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Neuronetics, Inc.
-
Annual Revenue
$74.89 M (USD)4.96as on Dec 31, 2024
-
Net Profit
-$43.71 M (USD)-44.78as on Dec 31, 2024
-
EBITDA
-$32.49 M (USD)-13.81as on Dec 31, 2024
-
Total Equity Funding
$118.69 M (USD)
in 7 rounds
-
Latest Funding Round
Not available
-
Investors
Pfizer
& 12 more
-
Employee Count
716
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of NeuroStar
NeuroStar is a publicly listed company on the NASDAQ with ticker symbol STIM in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of NeuroStar
NeuroStar offers a comprehensive portfolio of products and services, including NeuroStar TMS System and NeuroStar Advanced Therapy.
Non-invasive treatment using magnetic pulses for depression relief.
Adjunct treatment for OCD and anxious depression in patients.
People of NeuroStar
Unlock access to complete
Unlock access to complete
Funding Insights of NeuroStar
NeuroStar has successfully raised a total of $118.69M across 7 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in NeuroStar
NeuroStar has secured backing from 13 investors, including venture fund and institutional investors. Prominent investors backing the company include Pfizer, General Electric and New Leaf Venture Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private debt investments are managed for middle-market companies.
|
Locked | Locked | Locked | |
|
Strategic investments in healthcare technologies and data innovations.
|
Locked | Locked | Locked | |
|
Early-stage US healthcare investments are made by Accuitive Medical Ventures.
|
Locked | Locked | Locked |
Investor details for NeuroStar
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by NeuroStar
Investment portfolio details for NeuroStar
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - NeuroStar
Detailed financials for NeuroStar
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Neurostar Comparisons
Peer comparison for NeuroStar
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of NeuroStar
NeuroStar operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Flow Neuroscience, Magstim, Soterix Medical, Neuroprex and NeuroQore, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of a wearable device for stress and anxiety management
|
|
| Locked | Locked | Locked |
Neurotechnology solutions for EEG, TMS, and tDCS are developed.
|
|
| Locked | Locked | Locked |
Non-invasive neuromodulation devices for mood disorders are manufactured.
|
|
| Locked | Locked | Locked |
Wearable devices are developed to modulate tissues for neurological diseases.
|
|
| Locked | Locked | Locked |
Monophasic rTMS systems for depression treatment are developed by NeuroQore.
|
Detailed competitors of NeuroStar
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Neurostar
Complete news archive for NeuroStar
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about NeuroStar
NeuroStar was founded in 2003 and raised its 1st funding round 6 years after it was founded.
NeuroStar is headquartered in Malvern, United States. It is registered at Malvern, Pennsylvania, United States.
NeuroStar is a funded company, having raised a total of $118.69M across 7 funding rounds to date.
As of Dec 31, 2024, the latest employee count at NeuroStar is 716.
Annual revenue of NeuroStar is $74.89M as on Dec 31, 2024.
NeuroStar was founded in 2003 and is headquartered in Malvern, United States. Operations center on the development of non-drug, non-invasive devices utilizing MRI-strength pulsed magnetic fields for neurorehabilitation. Therapeutic applications target central nervous system disorders, with TMS Therapy serving as an FDA-cleared option for adults with major depressive disorder who have not responded adequately to prior antidepressant treatments.
NeuroStar's top competitors include Flow Neuroscience, Magstim and Neuroprex.
NeuroStar offers NeuroStar TMS System and NeuroStar Advanced Therapy.
Yes, NeuroStar is publicly traded on NASDAQ under the ticker symbol STIM.
NeuroStar has 13 investors. Key investors include Pfizer, General Electric, New Leaf Venture Partners, SLR Investment, and Ascension Ventures.
The ticker symbol of NeuroStar is STIM on NASDAQ.